SCHEMBL7112385

SCHEMBL7112385

NCC(=O)OC(=O)c1cccc(C(F)(F)F)c1

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.56
LMNA P02545 4/20 0.49
NPSR1 Q6W5P4 2/20 0.49
SRD5A2 P31213 1/20 0.48
ALDH1A1 P00352 3/20 0.47
POLB P06746 2/20 0.47
HPGD P15428 3/20 0.46
PTGS1 P23219 3/20 0.46
P2RX1 P51575 1/20 0.46
NPC1 O15118 1/20 0.44
CYP1A2 P05177 1/20 0.44
HSP90AA1 P07900 1/20 0.44
XBP1 P17861 1/20 0.44
CYP2C19 P33261 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4946599 0.86 CES2 (0.57) CES2LMNANPSR1SRD5A2ALDH1A1
SCHEMBL9200320 0.85 CES2 (0.69) CES2LMNANPSR1SRD5A2ALDH1A1
SCHEMBL31406174 0.85 CES2 (0.69) CES2LMNANPSR1SRD5A2ALDH1A1
SCHEMBL29381825 0.84 LOXL2 (0.47) LMNAALDH1A1HPGDSMN1; SMN2
SCHEMBL11468763 0.82 ALDH1A1 (0.55) CES2LMNANPSR1SRD5A2ALDH1A1
SCHEMBL9200329 0.81 CES2 (0.62) CES2LMNANPSR1SRD5A2ALDH1A1
SCHEMBL28392703 0.80 CES2 (0.61) CES2LMNANPSR1SRD5A2ALDH1A1
SCHEMBL311526 0.79 CES2 (0.65) CES2LMNANPSR1SRD5A2ALDH1A1
SCHEMBL10960544 0.78 CES2 (0.54) CES2LMNANPSR1SRD5A2ALDH1A1
Hydrochloric Acid SCHEMBL310751 0.78 CES2 (0.62) CES2LMNANPSR1SRD5A2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1351924-A2 DIAMINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY Bristol-Myers Squibb Pharma Company (US) 2003-10-15 EP disclosed
WO-2002050019-A2 DIAMINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY BRISTOL-MYERS SQUIBB PHARMA CO. (US) 2002-06-27 WO disclosed